Rachel Hanson

Rachel Hanson is a seasoned Senior BioProcess Associate at MacroGenics, Inc. since March 2012, specializing in the development of monoclonal antibody-based therapies for cancer, autoimmune disorders, and infectious diseases. Expertise includes the creation of high-yield, scalable CHO-S cell lines and optimization of cell culture processes across various bioreactor scales. Previous roles at MacroGenics encompassed Bioprocess Associate II and Research Associate II, focusing on large-scale bioprocessing and recombinant mammalian cell line analysis in cGMP environments. Prior to this, Rachel served as a Teaching Assistant at the University of Delaware, facilitating laboratory courses in biology. Educational credentials include a Master of Science in Cell Biology and Anatomy from the University of Delaware, a Post-baccalaureate Fellowship in Infectious Disease from the National Institute of Health/NIAID, and a Bachelor of Science in Biology from the University of Maryland Eastern Shore.